These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 18415767

  • 1. Hand function tests are important and sensitive tools for assessment of treatment response in patients with rheumatoid arthritis.
    Eberhardt K, Sandqvist G, Geborek P.
    Scand J Rheumatol; 2008; 37(2):109-12. PubMed ID: 18415767
    [Abstract] [Full Text] [Related]

  • 2. Hand function and activity limitation according to health assessment questionnaire in patients with rheumatoid arthritis and healthy referents: 5-year followup of predictors of activity limitation (The Swedish TIRA Project).
    Björk MA, Thyberg IS, Skogh T, Gerdle BU.
    J Rheumatol; 2007 Feb; 34(2):296-302. PubMed ID: 17299837
    [Abstract] [Full Text] [Related]

  • 3. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N, Singh G, Yamanaka H.
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [Abstract] [Full Text] [Related]

  • 4. Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.
    Baumgartner SW, Fleischmann RM, Moreland LW, Schiff MH, Markenson J, Whitmore JB.
    J Rheumatol; 2004 Aug; 31(8):1532-7. PubMed ID: 15290731
    [Abstract] [Full Text] [Related]

  • 5. Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
    Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C, Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.
    Arthritis Rheum; 2007 May 15; 57(4):679-85. PubMed ID: 17471545
    [Abstract] [Full Text] [Related]

  • 6. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.
    Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, Massara A, Nacci F, Secchi ME, Manganelli S, Salaffi F, Bambara ML, Bombardieri S, Cutolo M, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Grassi W, Lapadula G, Cerinic MM, Montecucco C, Trotta F, Triolo G, Valentini G, Valesini G, Ferraccioli GF, GISEA group.
    J Rheumatol; 2007 Aug 15; 34(8):1670-3. PubMed ID: 17611987
    [Abstract] [Full Text] [Related]

  • 7. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
    Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A.
    Semin Arthritis Rheum; 2011 Aug 15; 41(1):81-9. PubMed ID: 21168187
    [Abstract] [Full Text] [Related]

  • 8. Disease activity and disability in women and men with early rheumatoid arthritis (RA): an 8-year followup of a Swedish early RA project.
    Hallert E, Björk M, Dahlström O, Skogh T, Thyberg I.
    Arthritis Care Res (Hoboken); 2012 Aug 15; 64(8):1101-7. PubMed ID: 22392813
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis.
    Blom M, Kievit W, Donders AR, den Broeder AA, Straten VH, Kuper I, Visser H, Jansen TL, Brus HL, Branten AJ, van de Laar MA, van Riel PL.
    J Rheumatol; 2011 Nov 15; 38(11):2355-61. PubMed ID: 21885487
    [Abstract] [Full Text] [Related]

  • 10. Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients.
    Flint-Wagner HG, Lisse J, Lohman TG, Going SB, Guido T, Cussler E, Gates D, Yocum DE.
    J Clin Rheumatol; 2009 Jun 15; 15(4):165-71. PubMed ID: 19279507
    [Abstract] [Full Text] [Related]

  • 11. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
    Ernestam S, Hafström I, Werner S, Carlström K, Tengstrand B.
    J Rheumatol; 2007 Jul 15; 34(7):1451-8. PubMed ID: 17477470
    [Abstract] [Full Text] [Related]

  • 12. [The impact of therapy with TNF-blockers on health-related quality of life in rheumatoid arthritis patients. A pilot study].
    Abalos Medina GM, Ruiz Villaverde G, Sánchez Cano D, Ruiz Villaverde R, Ramírez Rodrigo J, Raya Álvarez E, Villaverde Gutiérrez C.
    Reumatol Clin; 2011 Jul 15; 7(3):167-71. PubMed ID: 21794808
    [Abstract] [Full Text] [Related]

  • 13. Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis.
    Mattey DL, Brownfield A, Dawes PT.
    J Rheumatol; 2009 Jun 15; 36(6):1180-7. PubMed ID: 19447930
    [Abstract] [Full Text] [Related]

  • 14. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y, Youssef SS, El Gaafary M.
    J Rheumatol; 2006 Mar 15; 33(3):490-7. PubMed ID: 16511918
    [Abstract] [Full Text] [Related]

  • 15. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
    Keystone E, Freundlich B, Schiff M, Li J, Hooper M.
    J Rheumatol; 2009 Mar 15; 36(3):522-31. PubMed ID: 19228659
    [Abstract] [Full Text] [Related]

  • 16. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC, Chung SJ, Park YB, Lee SK.
    Scand J Rheumatol; 2008 Mar 15; 37(3):173-8. PubMed ID: 18465450
    [Abstract] [Full Text] [Related]

  • 17. Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis.
    Guis S, Balandraud N, Bouvenot J, Auger I, Toussirot E, Wendling D, Mattei JP, Nogueira L, Mugnier B, Legeron P, Landt O, Serre G, Roudier J, Roudier C.
    Arthritis Rheum; 2007 Dec 15; 57(8):1426-30. PubMed ID: 18050183
    [Abstract] [Full Text] [Related]

  • 18. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P, West J, Jones H, Gibson T.
    J Rheumatol; 2001 Nov 15; 28(11):2409-15. PubMed ID: 11708411
    [Abstract] [Full Text] [Related]

  • 19. Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials.
    Smolen JS, Aletaha D, Grisar JC, Stamm TA, Sharp JT.
    Ann Rheum Dis; 2010 Jun 15; 69(6):1058-64. PubMed ID: 19717399
    [Abstract] [Full Text] [Related]

  • 20. Hand function in women and men with early rheumatoid arthritis. A prospective study over three years (the Swedish TIRA project).
    Björk M, Thyberg I, Haglund L, Skogh T.
    Scand J Rheumatol; 2006 Jun 15; 35(1):15-9. PubMed ID: 16467035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.